Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Essex Bio-Technology ( (HK:1061) ).
Essex Bio-Technology Limited announced an interim dividend of HKD 0.07 per share for the six months ending June 30, 2025. This announcement reflects the company’s financial performance and commitment to returning value to shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (HK:1061) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Essex Bio-Technology stock, see the HK:1061 Stock Forecast page.
More about Essex Bio-Technology
Essex Bio-Technology Limited operates in the biotechnology industry, focusing on the development and commercialization of biopharmaceutical products. The company primarily offers products related to ophthalmology and dermatology, targeting markets that require advanced therapeutic solutions.
Average Trading Volume: 1,622,752
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.28B
Learn more about 1061 stock on TipRanks’ Stock Analysis page.